About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...

A study on GLP1RA medications found that behavioral side effects likely do not result from direct action on GLP1R.

He spoke on the chances of getting popular weight loss drugs like Saxenda and Wegovy covered again for state employees, ...

Novo Nordisk - which manufactures Wegovy, Ozempic and Saxenda - misreported, under-reported or did not disclose funding it ...

A new study conducted by researchers from the University of Eastern Finland the Karolinska Institutet explored the ways that ...

It's not just celebrities and TikTok creators jumping on the weight loss drug hype - more than 500,000 people in the UK are ...

Already, GLP-1 weight loss prescriptions Wegovy, Rybelsus and Saxenda—along with Ozempic—are the “single biggest driver” of employer health costs, adding 1% to the total premium expense ...

Nearly 400 people have required medical treatment since jabs including Wegovy, Mounjaro and Saxenda were rolled out, figures ...

Lean mass constituted 30.8% of total body weight lost for adults who received a GLP-1 drug during a randomized controlled ...

The company behind popular weight-loss drugs failed to disclose millions of pounds it paid to healthcare groups and patient ...